During the first week after birth, some premature infants develop
bleeding in the brain (intraventricular hemorrhage), for which there is no
known treatment. Bleeding severity is most often minimal (grades I and II),
causing no noticeable brain damage. Grade III bleeding increases the risk of
developing
hydrocephalus (a buildup of excess cerebrospinal fluid
within the brain), brain damage, or both. Grade IV is used to describe
extensive bleeding that has led to brain damage that is visible on image
studies.
The more immature the brain, the more fragile the brain's blood
vessels and the more sensitive they are to changes in blood pressure. Extremely
premature infants are therefore at greatest risk for intraventricular
hemorrhage. While up to 80% of infants born at 23 to 24 weeks' gestation
develop this condition, it is very rare among infants born at or beyond 35
weeks.1
Regardless of an infant's
gestational age at birth, the risk of intraventricular
hemorrhage drops significantly after the first 72 hours of life and is
negligible after 7 days of age. Very premature infants typically have an
ultrasound of the head (cranial ultrasound) 3 to 7
days after birth to check for intraventricular hemorrhage. Those who show signs
of bleeding are periodically checked thereafter.
Prevention measures that can reduce the risk of intraventricular
hemorrhage include:1
- Corticosteroid treatment, given to the
mother before the birth. This treatment is typically given to help fetal lungs
develop before a premature birth and is thought to make blood vessels less
likely to bleed.
- Indomethacin, given to the infant after birth.
This
non-steroidal anti-inflammatory drug (NSAID) tightens
the brain's blood vessels (vasoconstriction), which helps control sudden
changes in blood pressure in the brain.